COMP <GO>
BBOT vs SLGL // FREE CASH FLOW YIELD
BridgeBio Oncology Therapeutics Inc. (NASDAQ) VS. Sol-Gel Technologies Ltd. (NASDAQ) • 15-METRIC TALLY: BBOT 0
— SLGL 3
■ METRIC PARITY
LAST: $2.62 (-2.96%) • MKT CAP: $216.5M
fcf-yield
—
LAST: $68.35 (-0.45%) • MKT CAP: $224.8M
fcf-yield
0.12%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BBOT VS. SLGL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BBOT | SLGL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | — | 0.12% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -38.90% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -31.60% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 68.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 8.54 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 6/9 | -4.00 | SLGL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 24.1 | 41.5 | -17.47 | SLGL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $216.5M | $224.8M | -$8.3M | SLGL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BBOT REV | SLGL REV | BBOT GROSS % | SLGL GROSS % | BBOT FCF | SLGL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $19.4M | — | — | -$114.5M | $275.0K |
| FY 2024 | $0 | $11.5M | — | — | -$55.1M | -$13.9M |
| FY 2023 | $0 | $1.6M | — | — | — | -$17.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BBOT // BETA —
SLGL // BETA —